Teachers Advisors’s Tempest Therapeutics TPST Stock Holding History

Teachers Advisors’s Portfolio TPST Stock Details TPST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-23	Closed	-$127K	–	3167
2017 Q1	$127K	Hold	23	–	–	﹤0.01%	2948
2016 Q4	$104K	Buy	23 +8	+53%	+$99.7K	﹤0.01%	3003
2016 Q3	$319K	Hold	15	–	–	﹤0.01%	2692
2016 Q2	$232K	Buy	15 +3	+25%	+$68.5K	﹤0.01%	2816
2016 Q1	$334K	Hold	12	–	–	﹤0.01%	2554
2015 Q4	$344K	Hold	12	–	–	﹤0.01%	2619
2015 Q3	$299K	Hold	12	–	–	﹤0.01%	2692
2015 Q2	$991K	Buy	12 +3	+33%	+$275K	﹤0.01%	2127
2015 Q1	$888K	Buy	9 +2	+29%	+$266K	﹤0.01%	2112
2014 Q4	$934K	Hold	7	–	–	﹤0.01%	2058
2014 Q3	$351K	Hold	7	–	–	﹤0.01%	2594
2014 Q2	$194K	Buy	7 +3	+75%	+$70.7K	﹤0.01%	2947
2014 Q1	$103K	Hold	4	–	–	﹤0.01%	3026
2013 Q4	$106K	Hold	4	–	–	﹤0.01%	3022
2013 Q3	$115K	Hold	4	–	–	﹤0.01%	2983
2013 Q2	$160K	Buy	+4	New	+$150K	﹤0.01%	2874

Other funds holding TPST

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Teachers Advisors's TPST Position: Q2 2017 in Review

Teachers Advisors sold out of Tempest Therapeutics (TPST) in Q2 2017, closing a stake of 23 shares — an estimated $127K sold.

Teachers Advisors first reported a position in TPST in Q2 2013 and held it in 16 quarters. The position peaked at $991K in Q2 2015. 54 funds tracked by Wall St. Rank hold TPST as of Q2 2017.

Teachers Advisors reported no remaining Tempest Therapeutics position as of Q2 2017 after selling out during the quarter.
Teachers Advisors sold 23 Tempest Therapeutics shares in Q2 2017, an estimated $127K.
Teachers Advisors first reported a position in Tempest Therapeutics in Q2 2013 and held it in 16 quarters.
Teachers Advisors's Tempest Therapeutics position peaked at $991K in Q2 2015.
54 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q2 2017.

Based on Teachers Advisors's 13F filing for Q2 2017, filed 10 Aug 2017.